Histological behavior of glutaraldehyde cross-linked bovine collagen injected into the human bladder for the treatment of vesicoureteral reflux
Détails
ID Serval
serval:BIB_46962B6F12B5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Histological behavior of glutaraldehyde cross-linked bovine collagen injected into the human bladder for the treatment of vesicoureteral reflux
Périodique
Journal of Urology
ISSN
0022-5347
Statut éditorial
Publié
Date de publication
08/1994
Peer-reviewed
Oui
Volume
152
Numéro
2 Pt 2
Pages
632-5
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Aug
Research Support, Non-U.S. Gov't --- Old month value: Aug
Résumé
Endoscopic subureteral collagen injection has become an accepted means for the treatment of vesicoureteral reflux in children. The aim of this study was to evaluate the histological behavior of glutaraldehyde cross-linked bovine collagen implants. The specimens were harvested from 29 patients who underwent reimplant surgery 2 to 30 months (mean 9.5) after unsuccessful subureteral injection therapy. In addition to routine hematoxylin and eosin staining, a new staining method (solophenyl red 3BL) able to demonstrate selectively neoformation of types I and III human collagen, was applied. Invasion of host fibroblasts into the bovine implant and the formation of endogenous types I and III collagen were demonstrated in all 29 cases. Adverse histological reactions were rare and, if present, they were predominantly of an inflammatory nature.
Mots-clé
Biocompatible Materials
Calcinosis/etiology/pathology
Collagen/administration & dosage/adverse effects/metabolism/*therapeutic
use
Cross-Linking Reagents
Endoscopy
Fibroblasts/pathology
Foreign-Body Reaction/etiology/pathology
Humans
Inflammation/etiology/pathology
Injections
Prostheses and Implants
Urinary Bladder
Vesico-Ureteral Reflux/metabolism/pathology/*therapy
Pubmed
Web of science
Création de la notice
28/02/2008 10:25
Dernière modification de la notice
20/08/2019 13:52